CA1061338A - Procede de preparation de derives substitues de l'acide prostanoique_ - Google Patents
Procede de preparation de derives substitues de l'acide prostanoique_Info
- Publication number
- CA1061338A CA1061338A CA229,850A CA229850A CA1061338A CA 1061338 A CA1061338 A CA 1061338A CA 229850 A CA229850 A CA 229850A CA 1061338 A CA1061338 A CA 1061338A
- Authority
- CA
- Canada
- Prior art keywords
- formula
- oxo
- hydrogen
- carbon atoms
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 10
- 239000001257 hydrogen Substances 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 14
- 229910052763 palladium Inorganic materials 0.000 claims description 6
- 229920002554 vinyl polymer Polymers 0.000 claims description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 3
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- XNMYNYSCEJBRPZ-UHFFFAOYSA-N 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine Chemical compound C1=CC=C2C(OCCN(C)C)=NC(CCCC)=CC2=C1 XNMYNYSCEJBRPZ-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 229960005038 quinisocaine Drugs 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 abstract description 2
- 208000021822 hypotensive Diseases 0.000 abstract description 2
- 230000001077 hypotensive effect Effects 0.000 abstract description 2
- 230000003361 anti-bronchoconstrictory effect Effects 0.000 abstract 1
- 230000001595 contractor effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 26
- 239000000203 mixture Substances 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000219495 Betulaceae Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 235000014066 European mistletoe Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 241000221012 Viscum Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- YCQDGOHCBPHVLE-PMACEKPBSA-N (1r,2s)-1-hept-2-enyl-2-oct-1-enylcyclopentane Chemical compound CCCCCCC=C[C@H]1CCC[C@@H]1CC=CCCCC YCQDGOHCBPHVLE-PMACEKPBSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 101100163433 Drosophila melanogaster armi gene Proteins 0.000 description 1
- 101100348555 Escherichia coli (strain K12) nhaR gene Proteins 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000005587 carbonate group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- -1 chloromethylen Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000001940 cyclopentanes Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000007519 figuring Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7421602A FR2275443A1 (fr) | 1974-06-21 | 1974-06-21 | Nouveau procede de preparation de derives substitues de l'acide prostanoique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1061338A true CA1061338A (fr) | 1979-08-28 |
Family
ID=9140359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA229,850A Expired CA1061338A (fr) | 1974-06-21 | 1975-06-20 | Procede de preparation de derives substitues de l'acide prostanoique_ |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5113751A (xx) |
BE (1) | BE830475A (xx) |
CA (1) | CA1061338A (xx) |
CH (1) | CH596163A5 (xx) |
DD (1) | DD118412A5 (xx) |
DE (1) | DE2526355A1 (xx) |
DK (1) | DK142171B (xx) |
ES (1) | ES438725A1 (xx) |
FR (1) | FR2275443A1 (xx) |
GB (1) | GB1478262A (xx) |
IE (1) | IE41835B1 (xx) |
IL (1) | IL47437A (xx) |
LU (1) | LU72786A1 (xx) |
NL (1) | NL7507431A (xx) |
SE (1) | SE7505967L (xx) |
SU (1) | SU577977A3 (xx) |
ZA (1) | ZA753959B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022912A (en) * | 1976-02-09 | 1977-05-10 | Miles Laboratories, Inc. | Use of 1-decarboxy-1-hydroxymethyl-PGE1 in therapeutic bronchodilation |
JPH06104644B2 (ja) * | 1986-03-04 | 1994-12-21 | 住友化学工業株式会社 | 光学活性なシクロペンテノン誘導体の製造法 |
-
1974
- 1974-06-21 FR FR7421602A patent/FR2275443A1/fr active Granted
-
1975
- 1975-05-26 SE SE7505967A patent/SE7505967L/ not_active Application Discontinuation
- 1975-06-06 IL IL47437A patent/IL47437A/xx unknown
- 1975-06-12 DE DE19752526355 patent/DE2526355A1/de not_active Withdrawn
- 1975-06-19 DD DD186765A patent/DD118412A5/xx unknown
- 1975-06-20 ES ES438725A patent/ES438725A1/es not_active Expired
- 1975-06-20 IE IE1383/75A patent/IE41835B1/en unknown
- 1975-06-20 SU SU7502145918A patent/SU577977A3/ru active
- 1975-06-20 BE BE157537A patent/BE830475A/xx unknown
- 1975-06-20 CH CH808275A patent/CH596163A5/xx not_active IP Right Cessation
- 1975-06-20 CA CA229,850A patent/CA1061338A/fr not_active Expired
- 1975-06-20 LU LU72786A patent/LU72786A1/xx unknown
- 1975-06-20 ZA ZA3959A patent/ZA753959B/xx unknown
- 1975-06-20 JP JP50074560A patent/JPS5113751A/ja active Pending
- 1975-06-20 NL NL7507431A patent/NL7507431A/xx not_active Application Discontinuation
- 1975-06-20 DK DK279475AA patent/DK142171B/da not_active IP Right Cessation
- 1975-06-23 GB GB2659175A patent/GB1478262A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ZA753959B (en) | 1977-01-26 |
IL47437A0 (en) | 1975-08-31 |
BE830475A (fr) | 1975-12-22 |
SU577977A3 (ru) | 1977-10-25 |
DK142171C (xx) | 1981-02-09 |
FR2275443B1 (xx) | 1976-10-22 |
IL47437A (en) | 1979-10-31 |
DD118412A5 (xx) | 1976-03-05 |
NL7507431A (nl) | 1975-12-23 |
IE41835B1 (en) | 1980-04-09 |
ES438725A1 (es) | 1977-03-16 |
DK142171B (da) | 1980-09-15 |
FR2275443A1 (fr) | 1976-01-16 |
IE41835L (en) | 1975-12-21 |
AU8211175A (en) | 1976-12-16 |
DE2526355A1 (de) | 1976-01-08 |
DK279475A (xx) | 1975-12-22 |
LU72786A1 (xx) | 1976-04-13 |
JPS5113751A (xx) | 1976-02-03 |
CH596163A5 (xx) | 1978-02-28 |
GB1478262A (en) | 1977-06-29 |
SE7505967L (sv) | 1975-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0001534B1 (fr) | Nouveaux dérivés du pyrrole, leur procédé de préparation et leurs applications en thérapeutique | |
CA1095520A (fr) | Procede de preparation de nouveaux derives de 20,21- dinoreburnamenine | |
HU199385B (en) | Process for producing alpha-halogencarboxylic acids and derivatives thereof, as well as pharmaceutical compositions comprising the same | |
EP0082049B1 (fr) | Nouveaux éthers dont les restes organiques comportent des atomes chiraux, leur préparation, leur application au dédoublement d'alcools ou de certains composés hémiacétaliques et les nouveaux produits dédoublés obtenus | |
EP0003445A1 (fr) | Dérivés d'aza-1 bicyclo(2,2,2)octane, leur procédé de préparation et produits intermédiaires, et médicaments les contenant | |
CA1061338A (fr) | Procede de preparation de derives substitues de l'acide prostanoique_ | |
CA1060039A (fr) | Derives des acides 3-benzoyl-phenylalcanoiques et-alcenoiques | |
FR2571369A1 (fr) | Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant | |
FR2550091A1 (fr) | Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne | |
EP0001021A2 (fr) | Nouveaux dérivés d'alcaloides pentacycliques, procédé de préparation, application à la synthèse de produits du groupe de l'éburnamonine et compositions pharmaceutiques | |
EP0012072B1 (fr) | Bêta-lactones dérivées de l'acide 2-hydroxy cyclopentane carboxylique, procédé pour leur préparation et compositions pharmaceutiques les renfermant | |
EP0082040B1 (fr) | Dérivés de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique | |
CA1200554A (fr) | Procede de preparation de nouveaux derives de l'aminomethyl 14-indole-4-methanol et de leurs sels | |
BE806848A (fr) | Medicament a base d'un derive de la quinoleine | |
EP0043811B1 (fr) | Nouvelles indolonaphtyridines et leur utilisation en tant que médicaments | |
JPS60109541A (ja) | ジアリ−ルインダン−1,3−ジオン,その調製及び使用 | |
CH617661A5 (xx) | ||
EP0153538B1 (fr) | Nouveaux dérivés de l'acide mélilotique, et médicaments les contenant | |
LU84412A1 (fr) | Nouveaux derives de 20,21-dinoreburnamenine eventuellement substitues sur le cycle e,procede et intermediaires de preparation,application comme medicament et compositions les renfermant | |
BE773937A (fr) | Procede de preparation d'aroyl-alkyl-piperidines | |
BE776316R (fr) | Nouveaux derives d'acides phenyl-acetiques substitues et procede pour leur | |
CH627193A5 (xx) | ||
CH618158A5 (xx) | ||
BE833577A (fr) | Derives d'acide prostanoique, leur procede de preparation et leurs applications | |
FR2578845A1 (fr) | Nouveaux derives de l'acide thiophene acetique, leur procede de preparation, les intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |